Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM | BSE: 500420

Expensive Performer

Download real time

3561.00 29.40 (0.83%)

726.9K

NSE+BSE Volume

High volume today

NSE 26 Sep, 2025 3:31 PM (IST)

Regulatory Approval

Torrent Pharma gets approval from South Africa's Competition Commission to acquire JB Chemicals See details

Torrent Pharmaceuticals Ltd. share price target

Torrent Pharmaceuticals Ltd. has an average share price target of 3746. The consensus estimate represents an upside of 5.20% from the last price of 3561. View 11 reports from 5 analysts offering long-term price targets for Torrent Pharmaceuticals Ltd..

Reco - This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)

Target - Broker has maintained previous recommendation but reduced share price target.

Reco - This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)

Target - Broker has maintained previous recommendation but increased share price target.

Load latest Google or static link led you to an intermediate page.

Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report		Discuss
	27 Sep 2025	Torrent Pharma	Consensus Share Price Target	3561.00	3929.42	-	10.35	buy	pdf Detailed Estimates
	26 May 2022	Torrent Pharma	ICICI Direct	3561.00	3235.00	2900.95 (22.75%)	Pre-Bonus/ Split	Buy	pdf post cache		Broker Report V-Mart Ltd. ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	07 Feb 2022	Torrent Pharma	Geojit BNP Paribas Target	3561.00	3095.00	2590.60 (37.46%)	Pre-Bonus/ Split	Buy	pdf post cache		Broker Report TORRENT PHARMA Geojit BNP Paribas Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Germany, Brazil, and internationally. The company... pdf Copy Link Share on Share on Share on Share on Alert
	27 Jan 2022	Torrent Pharma	Prabhudas Lilladhar	3561.00	3560.00	2657.65 (33.99%)	Pre-Bonus/ Split	Buy	pdf post cache		Broker Report TORRENT PHARMACEUTIC Prabhudas Lilladhar Torrent Pharma's (TRP) Q3FY22 performance was disappointing however we believe profitability/margins to normalize from FY23, aided by price hike in branded generic business and current cost escalation temporary. TRP's high exposure to branded generic business (~65-70% of total revenues) and chronic therapies provides comfort. The timely resolution of plants will pickup revenue growth in US and benefit operating leverage, going ahead. We expect 18% EPS CAGR over FY21-24E. We have cut our FY22E EPS by 6%... pdf Copy Link Share on Share on Share on Share on Alert
	26 Jan 2022	Torrent Pharma	Motilal Oswal Target	3561.00	2880.00	2683.50 (32.70%)	Target met	Neutral	pdf post cache		Broker Report US drags 3QFY22 earnings; inspections key to a revival Motilal Oswal TRP's 3QFY22 performance missed our estimate. The US Generics business remains the major drag on overall performance, with a lack of new approvals and a steep price erosion in the base business. Domestic Formulation (DF) remains in good stead, with healthy better-than-industry performance. The management intends to add medical representatives (MRs) to further strengthen the growth outlook in the DF segment. We reduce our FY22E/FY23E/FY24E EPS estimate by ~13%/7.5%/3.5% to factor in: a) a sharp reduction in the price realization of certain products... pdf Copy Link Share on Share on Share on Share on Alert
	26 Jan 2022	Torrent Pharma	ICICI Securities Limited Target	3561.00	3235.00	3161.00 (12.65%)	Pre-Bonus/ Split	Hold	pdf post cache		Broker Report Torrent Pharmaceuticals ICICI Securities Limited pdf Copy Link Share on Share on Share on Share on Alert
	01 Nov 2021	Torrent Pharma	Geojit BNP Paribas Target	3561.00	3200.00	2819.35 (26.31%)	Target met	Buy	pdf post cache		Broker Report TORRENT PHARMA Geojit BNP Paribas Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Germany, Brazil, and internationally. The company... pdf Copy Link Share on Share on Share on Share on Alert
	27 Oct 2021	Torrent Pharma	ICICI Securities Limited Target	3561.00	3110.00	2821.45 (26.21%)	Target met	Hold	pdf post cache		Broker Report Torrent Pharmaceuticals ICICI Securities Limited ... pdf Copy Link Share on Share on Share on Share on Alert
	03 Aug 2021	Torrent Pharma	Geojit BNP Paribas Target	3561.00	3416.00	3063.95 (16.22%)	Pre-Bonus/ Split	Buy	pdf post cache		Broker Report TORRENT PHARMA Geojit BNP Paribas Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Germany, Brazil, and internationally. The company... pdf Copy Link Share on Share on Share on Share on Alert
	28 Jul 2021	Torrent Pharma	Motilal Oswal Target	3561.00	2800.00	3084.70 (15.44%)	Target met	Neutral	pdf post cache		Broker Report DF on a strong footing; making inroads in Trade Generics Motilal Oswal TRP's 1QFY22 performance was largely in line with our estimates. Growth momentum in the Domestic Formulation (DF) business was offset by a muted showing in the US business and a higher tax rate. It continues to... pdf Copy Link Share on Share on Share on Share on Alert
	28 Jul 2021	Torrent Pharma	ICICI Securities Limited Reco Target	3561.00	3250.00	3084.70 (15.44%)	Target met	Hold	pdf post cache		Broker Report Torrent Pharmaceuticals ICICI Securities Limited A strong growth track in top brands, measured new launches (including innovative launches) besides strong balance sheet and comfort on corporate governance front are some key attributes of Sanofi... pdf Copy Link Share on Share on Share on Share on Alert
more loading

* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.

Advisor Screeners